BASEL MEDICAL GROUP LTD (BMGL) Stock Income Statement
NASDAQ:BMGL - Nasdaq - VGG0864B1031 - Common Stock - Currency: USD
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|
| Revenue | 10.05M | 9.70M | 10.66M | |||
| Operating Expenses | 5.63M | 5.41M | 6.33M | |||
| Selling, General, and Administrative Expenses | 3.59M | 3.27M | 4.04M | |||
| Operating Income | 4.42M | 4.29M | 4.33M | |||
| Interest Income/Expense | -176.20K | 57.00K | -74.20K | |||
| Other Income/Expense | -1.84M | -2.22M | -1.87M | |||
| Income Before Taxes | 2.40M | 2.13M | 2.39M | |||
| Income Tax | 331.80K | 348.30K | 408.50K | |||
| Net Income | 2.07M | 1.78M | 1.98M | |||
| EBITDA | 4.95M | 4.85M | 4.91M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | 0.11 | 0.10 | 0.11 | |||
| Statistics | ||||||
| Profit Margin | 20.62% | 18.38% | 18.56% | |||
| Operating Profit Margin | 44.01% | 44.27% | 40.65% | |||
All data in SGD